Tech Company Financing Transactions
MediQuest Therapeutics Funding Round
MediQuest Therapeutics, based in Seattle, secured $3.7 million from Integra Ventures, MASA Life Science Ventures and Novo Ventures.
Transaction Overview
Company Name
Announced On
12/31/2010
Transaction Type
Venture Equity
Amount
$3,684,000
Round
Undisclosed
Investors
Integra Ventures (Joseph Piper)
MASA Life Science Ventures (Sinclair Dunlop)
Novo Ventures (Jack Nielsen)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
300 East Pine St.
Seattle, WA 98122
USA
Seattle, WA 98122
USA
Phone
Website
Email Address
Overview
MediQuest Therapeutics, Inc. (MediQuest) is a specialty pharmaceutical company developing first- and best-in-class topical therapies in late-stage clinical development to treat patients suffering from inflammatory and infectious diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Frederick Dechow
Chief Financial Officer
Hans Lundin
Chief Medical Officer
Jeffrey Gregory
Chief Scientific Officer
Thomas Dooley
VP - Marketing
Tyler Ellison
VP - Regulatory Affairs
Carol Danielson
Browse more venture capital transactions:
Prev: 12/31/2010: Serus venture capital transaction
Next: 12/31/2010: UberMedia venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs